Risultati di ricerca
6 giorni fa · Il valore totale delle azioni vendute da Young ammonta a circa 102.880 dollari, con prezzi di vendita compresi tra 13,62 e 14,28 dollari. A seguito di queste transazioni, il direttore detiene ancora un numero significativo di azioni della società: l'ultimo documento SEC indica che la proprietà residua di Young è di 69.260 azioni ordinarie Novavax.
2 giorni fa · Over the past year, James Young has sold a total of 15,000 shares of Novavax Inc and has not purchased any shares. This recent transaction is part of a broader trend seen within the company, where ...
6 giorni fa · James F. Young, a director at Novavax Inc. (NASDAQ: NVAX ), has sold a total of 7,500 shares of the company's common stock, according to a recent SEC filing. The transactions, which took place...
2 giorni fa · NVAX. -5.93%. GuruFocus - On June 21, 2024, James Young, Director at Novavax Inc (NASDAQ:NVAX), sold 7,500 shares of the company at a price of $14.09 per share. The transaction was documented in a recent SEC Filing. Following this sale, the insider now owns 61,760 shares of Novavax Inc. Novavax Inc is a biotechnology company focused on the ...
1 giorno fa · Novavax, Inc. ( NASDAQ:NVAX - Get Free Report) Director James F. Young sold 7,500 shares of Novavax stock in a transaction on Friday, June 21st. The stock was sold at an average price of $14.09, for a total value of $105,675.00. Following the sale, the director now directly owns 61,760 shares of the company's stock, valued at $870,198.40.
2 giorni fa · James F. Young, director de Novavax Inc. (NASDAQ:NVAX), una empresa de biotecnología centrada en el desarrollo de vacunas, ha vendido recientemente un número significativo de acciones de la ...
5 giorni fa · James F Young, a Director at Novavax, sold 7,500 shares of Common Stock on June 18, 2024, with transaction prices of $13.62 and $14.28 per share, totaling $102,880. Following these transactions, Young directly owns 69,260 shares of Novavax.
